Hui Yan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 5%
Papers in
-
- Receptor Mechanisms and Signaling 9
- Immunology 33
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
- Atherosclerosis and Cardiovascular Diseases 6
- Co-authors
- William C. Wood (1 shared paper)Zehong Cao (1 shared paper)Lily Yang (1 shared paper)Jianhua Zhu (13 shared papers)F Yin (11 shared papers)Ting Chen (5 shared papers)Xiaoye Zheng (5 shared papers)Weiguo Zhu (7 shared papers)
- Journals
- Medical Physics (6 papers)PLoS ONE (6 papers)The Journal of Immunology (5 papers)International Immunopharmacology (3 papers)The Journal of Sexual Medicine (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Yan
119 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 139
- Cancer Research 413
- Immunology 430
- Radiation 175
- Molecular Biology 970
- Oncology 336
Countries citing papers authored by Hui Yan
This map shows the geographic impact of Hui Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yan more than expected).
Fields of papers citing papers by Hui Yan
This network shows the impact of papers produced by Hui Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yan. The network helps show where Hui Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. | 2003 | 240 |
| 2 | 2012 | 108 | |
| 3 | 2002 | 84 | |
| 4 | 2011 | 73 | |
| 5 | 2016 | 72 | |
| 6 | 2013 | 72 | |
| 7 | 2011 | 62 | |
| 8 | 2011 | 62 | |
| 9 | 2008 | 56 | |
| 10 | 2020 | 53 | |
| 11 | 2004 | 49 | |
| 12 | 2016 | 46 | |
| 13 | 2012 | 45 | |
| 14 | 2019 | 44 | |
| 15 | 2017 | 44 | |
| 16 | 2006 | 38 | |
| 17 | 2015 | 37 | |
| 18 | 2015 | 36 | |
| 19 | Treatment of congenital aneurysms of the left atrium and left atrial appendage. | 1999 | 36 |
| 20 | 2006 | 36 |
About Hui Yan
Hui Yan is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 2.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Receptor Mechanisms and Signaling (9 papers), Advanced Radiotherapy Techniques (8 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers), Medical Imaging Techniques and Applications (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). The work is most often cited by research in Cancer Research (413 citations), Immunology (430 citations), Radiation (175 citations), Molecular Biology (970 citations) and Oncology (336 citations). Hui Yan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include William C. Wood, Zehong Cao, Lily Yang, Jianhua Zhu, F Yin, Ting Chen, Xiaoye Zheng, Weiguo Zhu, Zhoubin Li and Jianhua Zhu. Their work appears in journals such as Medical Physics, PLoS ONE, The Journal of Immunology, International Immunopharmacology and The Journal of Sexual Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.